1.
BMJ Case Rep
; 20132013 Jun 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23780768
RESUMO
Aortitis is uncommon but well described in patients with polymyalgia rheumatica (PMR). While glucocorticoid remains the mainstay therapy for large-vessel vasculitis, there have been cases where tocilizumab therapy led to clinical and serological improvement in patients with relapsing or refractory disease. We report a case of life-threatening PMR with aortitis in the absence of manifestations related to giant cell arteritis, which, having failed to respond to corticosteroid therapy, was successfully treated with tocilizumab and emergency reconstruction of the ascending aorta. This case adds to the literature supporting the potential value of interleukin-6 inhibition in rare rheumatological conditions such as inflammatory aortitis.
Assuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Aorta/cirurgia , Aortite/diagnóstico , Interleucina-6/imunologia , Polimialgia Reumática/diagnóstico , Aortite/complicações , Aortite/tratamento farmacológico , Aortite/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Polimialgia Reumática/complicações , Polimialgia Reumática/tratamento farmacológico , Tomografia Computadorizada por Raios X , Resultado do Tratamento
2.
Int J Cardiol
; 159(3): e45-6, 2012 Sep 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22217483